Novel 11-Substituted Ellipticines as Potent Anticancer Agents with Divergent Activity against Cancer Cells

Ellipticines have well documented anticancer activity, in particular with substitution at the 1-, 2-, 6- and 9-positions. However, due to limitations in synthesis and coherent screening methodology the full SAR profile of this anticancer class has not yet been achieved. In order to address this shor...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Charlotte M., O’Sullivan, Elaine C., McCarthy, Florence O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631919/
https://www.ncbi.nlm.nih.gov/pubmed/31207878
http://dx.doi.org/10.3390/ph12020090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631919/
https://www.ncbi.nlm.nih.gov/pubmed/31207878
http://dx.doi.org/10.3390/ph12020090

Ejemplares similares